Palisade Capital Management LLC Pfizer Inc Transaction History

Palisade Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $565,683 - $808,239	-20,928 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$32.92 - $37.36 $4,147 - $4,707	126 Added 0.61%	20,928 $820,000
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $2,403 - $2,698	-65 Reduced 0.31%	20,802 $901,000
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $31,687 - $34,814	-845 Reduced 3.89%	20,867 $886,000
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $29,544 - $33,684	768 Added 3.67%	21,712 $948,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $4,894 - $5,937	142 Added 0.68%	20,944 $923,000
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $2.32 Million - $2.47 Million	-70,217 Reduced 77.15%	20,802 $755,000
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $61,713 - $71,596	-1,934 Reduced 2.08%	91,019 $3.23 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $88,139 - $93,518	2,650 Added 2.93%	92,953 $3.37 Million
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $2.8 Million - $3.08 Million	90,303	90,303 $3.22 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.